Significance of tissue specific and tissue non specific autoimmune reactions of Graves' disease

Clinical and Experimental Rheumatology

Volumn 14, Issue SUPPL. 15, 1996, Pages

  Kiljanski, J ^a   Nebes, V ^a   Wall, J R ^a  

^a Thyroid Eye Dis Research Laboratory   (United States)

Author keywords

antibodies; dermopathy; Graves' disease; muscle autoimmunity; ophthalmopathy; T lymphocytes; TSH receptor

Indexed keywords

AUTOANTIBODY; THYROTROPIN RECEPTOR;

AUTOIMMUNITY; CONFERENCE PAPER; CONNECTIVE TISSUE; GRAVES DISEASE; HUMAN; ORBIT; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THYROID GLAND;

ANIMALS; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASES; CALCIUM-BINDING PROTEINS; EYELID DISEASES; FOOT DISEASES; GRAVES DISEASE; HYPERTHYROIDISM; LACRIMAL APPARATUS; LEG DERMATOSES; MUSCULAR DISEASES; MYXEDEMA; OCULOMOTOR MUSCLES; SKIN DISEASES;

EID: 0029781833     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (94)

1. BURCH, WARTOFSKY L: Graves' ophthalmopathy: current concepts regarding pathogenesis and management, Endocrine Reviews 1993; 14: 747-93.
2. FATOURECHI V, PAJOUHI M, FRANSWAY AF: Dermopathy of Graves' disease (pretibial myxedema). Review of 150 cases. Medicine 1994; 73: 1-7.
3. BARTLEY GB: The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted county, Minnesota. Trans Amer Ophthl Soc 1994; 92: 477-588.
4. ORGIAZZI J, MADEC AM: Thyroid-stimulating hormone receptor and thyroid disease. Revue du praticien 1994; 44: 1184-91.
5. MORRIS JC, BERGERT ER, MCCORMICK DJ: Structure-function studies of the human thyroptropin receptor. Inhibition of binding of labelled thyrotropin (TSH) by synthetic human TSH receptor peptides. J Biol Chem 1993; 268: 10900-5.
6. GUPTA MK: Thyrotropin receptor antibodies: advances and importance of detection techniques in thyroid diseases. Clin Biochem 1992; 25: 193-9.
7. NAGAYAMA Y. RAPOPORT B: The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol Endocrinol 1992; 6: 145-56.
8. FURMANIAK J, REECE-SMITH BR: Structure of the TSH receptor. Exp Clin Endocrinol 1991; 97: 160-4.
9. UEDA Y, SUGAWA H, AKAMIZU T, OKUDA J, UEDA M, KOSUGI S, OHTA C, KIHOU Y, MORI T: Thyroid-stimulating antibodies in sera from patients with Graves' disease are heterologous in epitope recognition. Eur J Endocrinol 1995; 132: 62-8.
10. HEUFELDER AE, DUTTON CM, SARKAR G, DONOVAN KA, BAHN RS: Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 1993; 3: 297-300.
11. FELICIELLO A, PORCELLINI A, CIULLO I, BONAVOLONTA G, AVVEDIMENTO EV, FENZI G: Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 1993; 342: 337-8.
12. MARTIN A, DAVIES T: T cells and human autoimmune thyroid disease: emerging data show lack of need to invoke suppressor T cell problems. Thyroid 1992; 2: 247-61.
13. BOGNER U, SCHLEUSENER H, WALL JR: Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease. J Clin Endocrinol Metab 1984; 59: 734-8.
14. BOGNER U, WALL JR, SCHLEUSENER H: Cellular and antibody mediated cytotxicity in autoimmune thyroid disease. Acta Endocrinol 1987; 281 (Suppl.): 133-8.
15. TEXIER B, BEDIN C, TANG H, CAMOIN L, LAURENT-WINTER C, CHARREIRE J: Characterization and sequencing of a 40-amino-acid peptide from human thyroglobulin inducing experimental autoimmune thyroiditis. J Immunol 1992; 148: 3405-11.
16. HAMAD N, OKAMOTO Y, YAMAKAWA J, OHNO M, NOH J, YANO T, SHIBATA M, ITO K, MORI H: Investigation of antigenic determinants in thyroid peroxidase by synthesis of possible sequential peptides. Osaka City Medical J 1993; 39: 57-66.
17. KAWAKAMI Y, FISFALEN ME, DE GROOT LJ: Proliferative responses of peripheral blood mononuclear cells from patients with autoimmune thyroid diseases to synthetic peptide epitopes of human thyroid peroxidase. Autoimmunity 1992; 13: 17-26.
18. TANDON N, FREEMAN M, WEETMAN AP: T cell responses to synthetic thyroid peroxidase peptides in autoimmune thyroid disease. Clin Exp Immunol 1991; 86: 56-60.
19. ZANELLI E, HENRY M, MALTHIERY Y: Epitope mapping of human thyroid peroxidase defined seven epitopes recognized by sera from patients with thyroid pathologies. Cell Mol Biol 1993; 39: 491-501.
20. WEETMAN AP: Update: Thyroid-associated ophthalmopathy. Autoimmunity 1992; 12: 215-22.
21. WALL JR, BOUCHER BA, SALVI M, ZHANG ZG, KENNERDELL J, TYUTYUNIKOV A. GENOVESE C: Pathogenesis of thyroid associated ophthalmopathy: an autoimmune disorder of the eye muscle associated with Graves' hyperthyroidism and Hashimoto's thyroiditis. Clin Immunol Immunopathol 1993; 68: 1-8.
22. WEETMAN AP: Thyroid-associated eye disease: pathophysiology. Lancet. 1991; 338: 25-8 (Editorial)
23. KILJANSKI J, NEBES V, WALL JR: Is the ocular muscle cell a target of the immune system in endocrine ophthalmopathy? Intl Arch Allergy Immunol 1995; 106: 204-12.
24. TOCCAFONDI R, ROTELLA CM, ZONFERATI R, TANINI A: Humoral factors in Graves' ophthalmopathy. In: PINCHERA A, INGBAR SH, MCKENZIE JM, FENZI GF (Eds): Thyroid Autoimmunity. New York, Plenum Press, 1987; 99-108.
25. HEUFELDER AE, DUTTON CM, SARKAR G, DONOVAN KA, BAHN RS: Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 1993; 3: 297-300.
26. BAHN RS, GORMAN CA, JOHNSON CM, SMITH TJ: Presence of antibodies in the sera of patients with Graves' disease recognizing a 23-kilodalton fibroblast protein. J Clin Endocrinol Metab 1989; 69: 622-8.
27. CAMPBELL RJ: Pathology of Graves' ophthalmopathy. In: GORMAN CA. CAMPBELL RJ, DYER JA (Eds.): The Eye and Orbit in Thyroid Disease. NY. Raven Press 1984; 25-32.
28. SALVI M, MILLER A, WALL JR: Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in serum of patients with thyroid-associated ophthalmopathy. FEBS Lett 1988; 232: 135-9.
29. ZHANG ZG, SALVI M, MILLER A, BERNARD N, ARTHURS B, WALL JR: Restricted tissue reactivity of autoantibodies to a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Clin Immunol Immunopathol 1992; 62: 183-9.
30. HIROMATSU Y, SATO M, TANAKA K, SHOJI S, NONAKA K, CHINAMI M, FUKAZAWA H: Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative Western blot. Autoimmunity 1993; 14: 1-8.
31. KENDLER DL, ROOTMAN J, HUBER K, DAVIES TF: A 64 kDa membrane antigen is a recurrent epitope for natural autoantibodies in patients with Graves' thyroid and ophthalmic diseases. Clin Endocrinol 1991; 35: 539-47.
32. DAKOVSKA L, VULKOVA H, KOVATCHENA R, TODOROVA S, LOZANOV B, ATANASSOVA I, ASSIANOVA N, IVANOVA R, SARAFOVA A: Anti-eye muscle antibodies in patients with thyroid-asociated ophthalmopathy (TAO). Proc Annual Balkan Congress of Endocrinology, Bursa, Turkey, 1995 (abstract).
33. AHMAN A, BAKER JR, WEETMAN AP, WARTOFSKY L, KRETMAN TB, BURMAN KD: Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: Identification of serum immunoglobulins directed against determinants by immunoblotting and enzyme-linked immuno-absorbent assay, Clin Endocrinol Metab 1989; 64: 454-46.
34. PEROS P, KENDALL-TAYLOR P: The pathogenesis of thyroid-associated ophthalmopathy. J Endocrinol 1989; 122: 619-24.
35. WALL JR, SCALISE D, HAYES M, STOLARSKI C, SATO M, SALVI M, NEBES V: Native gel electrophoresis and isoelectric focusing of a 64 kDA protein shows that it is an important target for autoantibodies in patients with thyroid-associated ophthalmopathy and not expressed in other skeletal muscle. J Clin Endocrinol Metab 1995; 80: 1226-32.
36. MILLER A, ARTHURS B, BOUCHER A, LIBERMAN A, BERNARD N, SALVI M, WALL JR: Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity. Thyroid 1992; 2: 197-202.
37. SALVI M, BERNARD N, MILLER A, ZHANG ZG, GARDINI E, WALL JR: Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Thyroid 1991; 1: 207-213.
38. CHANG TC, CHANG TJ, HUANG YS, HUA KM, SU RJ, KAO SCS: Identification of autoantigen recognized by autoimmune ophthalmopathy sera with immunoblotting correlated with orbital computed tomography. Clin Immunol Immunopath 1992; 65: 161-6.
39. WALL JR, KILJANSKI J, NEBES V, STACHURA I, KENNERDELL JS: Should Graves' disease be considered a collagen disorder of the thyroid, skeletal muscle and connective tissue ? Horm Metab Res 1995; 27: 528-32.
40. ZHANG ZG, MEDEIROS-NETO G, IACONA A, LIMA N, HIROMATSU Y, SALVI M, TRILLER H, BERNARD N, WALL JR: Studies of cytotoxic activities against eye muscle antigens in patients with thyroid-associated ophthalmopathy. Acta Endocrinol 1989; 21 (Suppl. 2): 23-30.
41. MUNRO RE, LAMKI L, ROW VV, VOLPE R: Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrionol Metab 1973; 37: 286-92.
42. MAHIEU P, WINAND R: Demonstration of delayed hypersensitivity of retrobulbar and thyroid tissues in human exophthalmos. J Clin Endocrinol Metab 1972; 34: 1090-2.
43. MULLIN BR, LEVINSON RE, FRIEDMAN A, HENSON DE, WINAND RJ, KOHN LD: Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinol 1977; 100:351-66.
44. WALL JR, STRAKOSCH CR, FANG SL, INGBAR SH, BRAVERMAN LE: Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: effect of treatment with cyclophosphamide. Clin Endocrinol 1979; 10: 79-91.
45. KILJANSKI J , STOLARSKI C, NEBES V, WALL JR: Cell-mediated immunity against predicted epitopes of the 64 kDa protein 1D and eye muscle fractions in patients with thyroid-associated ophthalmopathy. J Endo Invest (in press).
46. STOVER C, OTTO E, BEYER J, KAHALY G: Cellular immunity and retrobulbar fibroblasts in Graves' ophthalmopathy. Thyroid 1994; 4: 161-5.
47. DONG Q, LUDGATE M, VASSART G: Cloning and sequencing of a novel 64 kDa autoantigen recognized by patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1991; 72: 1375-1381.
48. BERNARD NF, SALVI M, TYUTYUNIKOV A, GENOVESE C, LUDGATE M, WALL JR: Antibodies against the recombinant 64 kDa membrane protein are associated with ophthalmopathy in patients with thyroid autoimmunity. Clin Immunol Immunopath 1994; 70: 225-33.
49. BOUCHER, BERNARD N, MILLER A, RODIEN P, SALVI M, WALL JR: Two dimensional gel electrophoresis identifies minor differences in immunologically cross-reactive 64 kDa autoantigens in the thyroid and eye muscle. J Endocrinol Invest 1994; 17: 7-13.
50. WALL JR: Nature and significance of eye muscle antigens in endocrine ophthalmopathy. In KAHALY G. (Ed.): Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects. Dev Ophthalmol, Basel, Karger 1993; 25: 77-85.
51. SALVI M, ARTHURS B, MILLER A, BERNARD N, WALL JR: Patients with upper eyelid retraction and eye muscle autoantibodies may have subclinical thyroid autoimmunity. Clin Immunol Immunopathol 1995; 74: 44-50.
52. BARSOUK A, KILJANSKI J, STOLARSKI C, NEBES V, WALL JR: Role of immune reactivity against Muller's muscle antigens in the pathogenesis of stable chronic eyelid dysfunction. Proc Intl Symposium on "Progress in Thyroid-Associated Ophthalmopathy", Pittsburgh, Sept. 1995 (Abstract).
53. BARSOUK A, KILJANSKI J, STOLARSKI C, NEBES V, WALL JR: Antibody-dependent cell-mediated cytotoxicity against orbital tissue cells in patients with thyroid autoimmunity and orbital inflammatory disorders; correlation with clinical parameters. J Endo Invest (in press).
54. SALVI M, DE CHIARA F, GARDINI E, MINELLI R, BIANCONI L, ALNOVI A, RICCI R, NERI F, TOSI C, ROTI E: Echocardiographic diagnosis of pretibial myxedema in patients with autoimmune thyroid disease. Acta Endocrinol (Copenh) 1994; 131: 113-19.
55. BAHN RS, HEUFELDER AE: Orbital connective tissue in endocrine ophthalmopathy. In KAHALY G (Ed.): Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects. Dev. Ophthalmol. Basel, Karger 1993; 25: 46-57.
56. SMITH TJ, BAHN RS, GORMAN CA, CHEAVENS M: Stimulation of glycosaminoglycans accumulation by interferon gamma in cultured human retroocular fibroblasts. Invest Ophthalmol Vis Sci 1992; 33: 2037-42.
57. KAHALY G: Endocrine exophthalmos and urinary glycosaminoglycans Acta Endocrinologica 1989; 121 (Suppl. 2): 82-4.
58. CHANG CC, CHANG TC, KAO SC, KUO YF, CHIEN LF: Pentoxifylline inhibits the proliferation and glycosaminoglycans synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxede7 ma. Acta Endocrinologica 1993; 129: 322-7.
59. HIROMATSU Y, FUKAZAWA H, HOW J, WALL JR: Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy - roles of class II MHC antigen expression and interferon action on effector and target cells. Clin Exp Immunol 1987; 70: 593-603.
60. BARSOUK A, WENGROWITZ S, SCALISE D, STOLARSKI C, NEBES V, SATO M, WALL JR: New assays for the measurement of serum antibodies reactive with eye muscle membrane antigens confirms their importance in thyroid-associated ophthalmopathy. Thyroid 1995; 5: 195-200.
61. OLSON BR, KLEIN JI, BENNER R, BURDETT R, TRZEPACZ P, LEVEY GS: Hyperthyroid myopathy and the response to treatment. Thyroid 1991; 1: 137-41.
62. DUDGEON LS, URQUHART AL: Lymphorrhages in the muscle in exophthalmic goitre. Brain 1975; 49: 182-186.
63. MONTGOMERY PC, MAJUNDAR AS, SKANDERA CA, ROCKEY JH: The effect of immunization route and sequence of stimulation on the induction of IgA antibodies in tears. In: Current Eye Research. Vol. 3, Oxford, IRL Press Ltd. 1984; 861-5.
64. SOUSA M: Kinetics of the distribution of thymus and marrow cells in the peripheral lymphoid organs of the mouse: ecotaxis. Clin Exp Immunol 1971; 9: 371-7
65. DUA HS, GOMES JA, JINDAL VK, APPA SN, SCHWARTING R, EAGLE RC, DONOSO LA, LAIBSON PR: Mucosa specific lymphocytes in the human conjunctiva, corneoscleral limbus and lacrimal gland. Current Eye Research 1994; 13: 87-93.
66. MESTECKY J, MCGHEE JR, ARNOLD RR, MICHALEK SM, PRINCE SJ, BABB JL: Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest 1978; 61: 731-737.
67. BURNS CA, EBERSOLE JL, ALLANSMITH MR: Immunoglobulin A antibody levels in human tears, saliva and serum. Infect Immun 1982; 36: 1019-22.
68. MONTGOMERY PC, AYYILDIZ A, LEMAITRE-COELHO IM, VAERMAN JP, ROCKEY JH: Induction and expression of antibodies in secretions: the ocular immune system. Ann NY Acad Sci 1983; 409: 428-40.
69. TROKEL SL, JAKOBIEC FA: Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Ophthalmology 1981; 88: 553-64.
70. WALL JR, TREWIN A, FANG SL, INGBAR SH, BRAVERMAN LE: Studies of immunoreactivity to human lacrimal gland fractions in patients with ophthalmic Graves' disease. J Endocrinol Invest 1978; 1: 253-8.
71. ROSEN C, RAIKOW RB, BURDE RM, KENNERDELL JS, MOSSERI M, SCALISE D: Immunohistochemical evidence for IgA 1 involvement in Graves' ophthalmopathy. Ophthalmol 1992; 99: 146-52.
72. BLOCH KJ, BUCHANAN WW, WOHL MJ, BUNIM JJ: Sjögren's syndrome: a clinical, pathologic and serological study of sixty-two cases. Medicine 1965; 44: 186-90.
73. WHALEY K, WILLIAMSON J, CHISHOLM DM, WEBB J, MASON DK, BUCHANANØ WW: Sjögren's syndrome. I. Sicca components. Q J Med 1973; 42: 279-304.
74. BARSOUK A, FRAITURE B, PEELE KA, STOLARSKI C, NEBES V, HAYES M, KENNERDELL JS, WALL JR: Increased Superoxide dismutase activity in lacrimal secretions (tears) from patients with thyroid-associated ophthalmopathy. Proc 11th International Thyroid Congress, Toronto, Canada, September, 1995 (abstract).
75. MCDERMOTT MT, WEST SG, EMLEN JW, KIDD GS: Antideoxyribonucleic acid antibodies in Graves disease. J Clin Endocrinol Metab 1990; 71: 509-11.
76. BARTALENA L, MARTINO E, GRASSO L: Circulating antibodies to DNA related antigens in patients with autoimmune thyroid disorders. Autoimmunity 1992; 14: 33-6.
77. LOVISELLI A, VELLUZI F, PALA R, MARCELLO E, NURCHIS P, MATHIEU A, BARTELENA L, MARTINO E, GRASSO L: Circulating antibodies to DNA related antigens in patients with autoimmune thyroid disorders. Autoimmunity 1992; 14: 33-6.
78. KILJANSKI J, BARSOUK A, PEELE K, STACHURA I, PICKERELL J, NEBES V, WALL JR: Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: Is Graves' disease a collagen disorder? Proc 11th Intl Thyroid Congress, Toronto, September, 1995 (Abstract).
79. GORDON T. ISENBERG D: Organ specific and multisystem autoimmune disease: Part of a spectrum which may coexist in the same patient. Clin Rheumatol 1990; 9: 401-3.
80. PEROS P, PALMER JM, YEAMAN SJ, KENDALL-TAYLOR P: Anti-mitochondrial antibodies in patients with Graves' disease may not signify primary biliary cirrhosis. Post Grad Med J 1991; 70: 17-1880.
81. NERI S, GAMBUZZA C, BIONDI L, BASCHIERI L: Parameters of organ-specific and non-specific autoimmunity in patients with Basedow's disease and Basedow's ophthalmopathy. Changes induced by IVIG treatment. Clin Terapeutica 1992; 141:49-54.
82. KONSTADOULAKIS MM, KROUBOUZOS G, TOSCA A, PIPERINGOS G, MARAFELIA P, KONSTADOULAKIS M, VARELZIDIS A, KOUTRAS DA: Thyroid autoantibodies in the subsets of lupus erythematosus: correlation with other autoantibodies and thyroid function. Thyroidology 1993; 5: 1-7.
83. MCCOMBE PA, CHALK JB, PENDER MF: Familial occurrence of multiple sclerosis with thyroid diseases and systemic lupus erythematosus. J Neurol Sci 1990; 97: 163-71.
84. LOVISELLI A, VELLUZZI F, PALA R, MARCELLO A, NURCHIS P, MATHIEU A, DAGENAIS P, UROWITZ MB, GLADMAN DD, NORMAN CS: A family study of the anti-phospholipid syndrome associated with other autoimmune diseases. J Rheumatol 1992; 19: 1393-6.
85. ARNAOUT MA, NASARALLAH NS, EL-KHATEEB MS: Prevalence of abnormal thyroid function tests in connective tissue disease. Scand J Rheumatol 1994; 23: 128-32.
86. WINTER WE, MACLAREN NK: To what extent is "polyendocrine" serology related to the clinical expression of disease? In: DONIACH D, BOTTAZZO GF: Endocrine and Other Organ-Orientated Autoimmune Disorders. Clinical Immunology and Allergy , Philadelphia, London, Baillière Tindall, 1987; 109-123.
87. RAZ E, BEN-BASAT H, DAVIDI T, SHLOMAI Z, EILAT D: Cross-reactions of anti-DNA autoantibodies with cell surface proteins. Eur J Immunol 1993; 23: 383-90.
88. TOMER Y, DAVIES T: Infection, thyroid disease and autoimmunity. Endocrine Rev 1993; 14: 107-20.
89. SCHLEUSENER H, BOGNER U, PETERS H, KOTULLA P, SCHMIEG D, GTURETS A, MAYR WR: The relevance of genetic susceptibiity in Graves' disease and immune thyroiditis. Exp Clin Endo 1991; 97: 127-32.
90. YOKOYAMA N, NAGATAKI S: Pathogenesis of Graves' disease (Review). Nippon Rinsho 1994; 52: 1110-7.
91. MORI T, IMURA H, INOUE D, SATO K, ENOMOTO T, SUGAWA H, MAEDA M, INOKO H, TSUJI K: Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulatuions. Clin Endocr 1992; 36: 75-82.
92. RATANACHAIYAVONG S, LLOYD L, DARKE C, MCGREGOR AM: MHC extended haplotypes in families of patients with Graves' disease. Hum Immunol 1993; 36: 99-111.
93. INOUE D, SATO K, MAEDA M, INOKO H, TSUJI K, MORI T, IMURA H: Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: Genetic characteristics of euthyroid Graves' ophthalmopathy. Clin Endocrinol 1991; 34: 57-62.
94. FARID NR: Immunogenetics of autoimmune thyroid disorders. In: WALL JR (Ed.): Endocrinol Metab Clin North Am. W.B. Saunders Co. 1987; 16: 229-245.